MW 334.22 Da, Purity >98%. Product of the NAMPT reaction and a key intermediate in the biosynthesis of nicotinamide adenine dinucleotide (NAD+). Ameliorates glucose intolerance by restoring NAD+ levels in high-fat diet (HFD)-induced T2D mice. Enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation.
MW 334.22 Da, Purity >98%. Product of the NAMPT reaction and a key intermediate in the biosynthesis of nicotinamide adenine dinucleotide (NAD+). Ameliorates glucose intolerance by restoring NAD+ levels in high-fat diet (HFD)-induced T2D mice. Enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation.
Soluble in water to 100 mM.
Product of the NAMPT reaction and a key intermediate in the biosynthesis of nicotinamide adenine dinucleotide (NAD+). Ameliorates glucose intolerance by restoring NAD+ levels in high-fat diet (HFD)-induced T2D mice. Enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation.
This product is manufactured by BioVision, an Abcam company and was previously called 2733 β-Nicotinamide mononucleotide. 2733-250 is the same size as the 250 mg size of ab223879.
Protect from air and moisture.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab223879, beta-Nicotinamide mononucleotide, Key NAD+ intermediate
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com